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Spermatogonial stem cell transplantation (SSCT) is an experimen-
tal technique for transfer of germline between donor and recipient
males that could be used as a tool for biomedical research, preser-
vation of endangered species, and dissemination of desirable
genetics in food animal populations. To fully realize these poten-
tials, recipient males must be devoid of endogenous germline but
possess normal testicular architecture and somatic cell function
capable of supporting allogeneic donor stem cell engraftment and
regeneration of spermatogenesis. Here we show that male mice,
pigs, goats, and cattle harboring knockout alleles of the NANOS2
gene generated by CRISPR-Cas9 editing have testes that are germ-
line ablated but otherwise structurally normal. In adult pigs and
goats, SSCT with allogeneic donor stem cells led to sustained
donor-derived spermatogenesis. With prepubertal mice, allogeneic
SSCT resulted in attainment of natural fertility. Collectively, these
advancements represent a major step toward realizing the enor-
mous potential of surrogate sires as a tool for dissemination and
regeneration of germplasm in all mammalian species.
NANOS2 | spermatogonial stem cell | transplantation | surrogate sires |
livestock
The germline provides an eternal cellular link between gen-erations and in metazoans a male’s genetic contribution to
the next generation is delivered via sperm. Thus, the genesis of
sperm (i.e., spermatogenesis) is critical for the continuity and di-
versity of a species. In mammals, the continual sperm production
required for male fertility is a stem cell-based process centered on
the regenerative capacity of an undifferentiated spermatogonial
population (1, 2). In addition to sustaining steady-state spermato-
genesis, studies with mice have shown that a minor subset of the
undifferentiated spermatogonial population is able to regenerate
the spermatogenic lineage following isolation from donor tissue and
transplantation into the testes of a recipient male that is depleted of
endogenous germline (3, 4). These regenerative spermatogonia are
often referred to as spermatogonial stem cells (SSCs).
Spermatogonial stem cell transplantation (SSCT) has many po-
tential applications that could impact society in a major way. Au-
tologous SSCT has been lauded as a means to restore the fertility of
men who suffer from germline ablation due to collateral effects of
chemo- or radiotherapy, as well as men with a genetic mutation
rendering them infertile (5–7). Another potential application of
SSCT is with livestock for the propagation of elite genetics within
populations on a global scale (8). This accomplishment could pro-
vide an efficacious avenue for improving production characteristics
and in turn enhance the capacity to provide food security for the
expanding global population. In addition, SSCT in endangered
species has utility for preserving unique genetic lines, thereby con-
tributing to conservation efforts.
Application of SSCT in livestock or endangered species as a
breeding tool will require deployment in an allogeneic manner
and recipient males that completely lack endogenous germline so
that all sperm production is donor-derived. Previous studies with
rodent models have shown that recipient males rendered sterile
due to deficiency of the c-Kit gene (i.e., W/Wv mice) can attain
fertility following SSCT with cells from an immunologically
compatible donor or from an immunologically incompatible
donor (allogeneic transplant) when the recipient is subjected to
an immune suppression regimen (4, 9, 10). In addition, with
recipient mice that were prepared by treatment with a chemo-
toxic drug (i.e., busulfan) to deplete the endogenous germline
and not subjected to immune suppression, donor SSC engraft-
ment following transplantation into allogeneic recipients was
reported to be compromised due to immunological rejection
(10). These findings indicate that immunological compatibility
between donor and recipient is required for fertility attainment
by SSCT in mammals.
Significance
Transfer of sperm-producing stem cells isolated from a donor
male into testes of a recipient male has important applications
for preserving germplasm and as a conduit for widespread
dissemination of desirable genetics in livestock production. A
key aspect is surrogate males that lack endogenous germline
but are otherwise physiologically normal. Here we demon-
strate that male mice, pigs, and goats rendered genetically
sterile by CRISPR-Cas9 editing of the NANOS2 gene support
donor-derived spermatogenesis following allogeneic stem cell
transplantation. In addition, we show that CRISPR-Cas9 editing
of the NANOS2 gene in cattle leads to male germline ablation.
These findings represent a major advance toward surrogate
sires becoming a tool for disseminating and regenerating
germplasm in all mammals.
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Sourcing immunologically compatible recipients for application
of SSCT in either livestock or endangered species is improbable,
given breed/species divergence and immune suppression regimens
are unlikely to be desirable or feasible to apply. Preliminary SSCT
studies with large animals indicate that histoincompatability be-
tween donor and recipient is tolerated (11–15), but definitive ev-
idence of sustained donor-derived spermatogenesis and fertility is
currently lacking. Moreover, to date no studies have demonstrated
that donor-derived spermatogenesis can occur in livestock ren-
dered germline ablated from genetic deficiency. Here we show
unequivocally that application of SSCT in an allogeneic context is
tolerated in mice, pigs, and goats lacking endogenous germline via
genetic mutation of the NANOS2 gene and leads to sustain donor-
derived spermatogenesis as well as attainment of fertility via
natural mating.
Results
Allogeneic SSCT in Nanos2 Knockout Mice. To date, application of
SSCT in a context that will be deployable in livestock or en-
dangered species, that is, between immunologically incompatible
males where the recipient is germline ablated due to a genetic
deficiency and results in propagation of the donor haplotype via
natural breeding has not been demonstrated. To address this, we
first designed a proof-of-concept scheme with mice that involves
recipient males rendered sterile by inactivation of the evolu-
tionarily conserved germ cell-specific gene Nanos2 for allogeneic
SSCT with cells from an immunologically incompatible donor
male (Fig. 1A).
In previous studies, Nanos2 null mouse lines were created with
CD1 (i.e., ICR) outbred genetic backgrounds via targeted in-
sertion of LacZ or CRISPR-Cas9 editing to disrupt the coding
sequence (16, 17). These CD1 Nanos2−/− (knockout [KO]) males
were found to be sterile in adulthood with apparent ablation of
the germline, whereas males that were heterozygous for the
Nanos2 mutations (i.e., +/− genotype) or KO females were of
normal fertility. However, whether the testicular soma in Nanos2
KO males is of normal functionality to support spermatogenesis
from allogeneic wild-type (WT) germ cells has not been deter-
mined. Here mice from a CRISPR-Cas9 Nanos2 KO line that
were produced previously (16), were used as recipients for SSCT.
First, we confirmed sterility of Nanos2 KO males by pairing with
WT females. Over a 2-mo period, none of the Nanos2 KO males
(n = 3) sired offspring but copulatory plugs were evident in all
females confirming that mating had occurred. In comparison, all
male Nanos2+/− littermates were of normal fertility (SI Appendix,
Table S1). Also, all CRISPR-Cas9-generated Nanos2 KO fe-
males were of normal fertility (SI Appendix, Table S1). Next, at
∼2 mo of age one testis was removed from a group of Nanos2
KO males for phenotyping and the contralateral testis was
transplanted with SSCs isolated from testes of immunologically
incompatible Rosa26-LacZ (B6; 129s genetic background with
LacZ insertion in the Rosa26 locus) donor males. As expected,
the weight of nontransplanted testes from CRISPR-Cas9 Nanos2
KO males was found to be significantly (P < 0.01) reduced
by >81% (mean ± SEM and n = 3) compared to age-matched
heterozygous littermates (Fig. 1 B and C). In addition, exami-
nation of testicular cross-sections revealed that germline was
completely lacking in testes of the Nanos2 KO males (Fig. 1D
and SI Appendix, Fig. S1), confirming our previous findings (16).
Next, at 2 mo posttransplantation the contralateral transplanted
testis was collected and stained with X-Gal to detect colonies of
donor-derived spermatogenesis. We observed extensive alloge-
neic LacZ-labeled donor colonization in all CD1 Nanos2 KO
recipient testes with no signs of immunological rejection, e.g.,
inflammation or fibrosis (Fig. 1E). In addition, the degree of
colonization was greater in Nanos2 KO recipient testes com-
pared to testes of wild-type B6;129scv recipient males that had
been subjected to depletion of the endogenous germline by
busulfan treatment and transplanted with the same donor cell
population and concentration of cells (Fig. 1E). These findings
indicate that testes of Nanos2 KO mice provide an enhanced
environment for engraftment by transplanted wild-type SSCs.
Restoration of Natural Fertility Following Allogeneic SSCT in Nanos2
Knockout Mice. In previous studies, syngeneic SSCT into prepu-
bertal (5 to 12 days of age), but not adultWv/Wv recipient males,
resulted in efficient attainment of natural fertility (9, 10). In
addition, allogeneic SSCT in adult Wv/Wv recipients was able to
produce long-lasting colonies of donor-derived spermatogenesis
and offspring were produced by natural mating as long as the
recipient was subjected to immune suppression (10). However,
the efficiency of fertility attainment was quite low (∼24% of
males) and the number of donor cells transplanted per testis
proved to be a limiting factor (10). Here we asked whether
Nanos2 KO recipients subjected to allogeneic SSCT without
immune suppression could attain fertility by natural mating
(Fig. 2A). To standardize the donor cell population, primary
cultures of undifferentiated spermatogonia established from
Rosa26-LacZ mice that are alloantigen histoincompatible with
CD1 recipient mice were used. We transplanted 3 to 8 × 104
donor cells into either one or both testes of six Nanos2 KO re-
cipient males ranging in age from 21 to 43 d at the time of
transplant (SI Appendix, Table S2). At 30 d after transplantation,
Fig. 1. Allogeneic SSCT in Nanos2 knockout recipient mice. (A) Schematic of
the experimental strategy. (B) Representative images of testes from adult
mice possessing one (+/−) or two (−/−) Nanos2 alleles inactivated by CRISPR-
Cas9 gene editing. (C) Quantitative comparison of testis weights between
adult Nanos2 +/− and −/−mice. Data are mean ± SEM for n = 3 different males
and six testes of each genotype and * denotes significantly different at P <
0.05. (D) Representative images of hematoxylin & eosin-stained testis cross-
sections from adult Nanos2 +/− and −/− mice. (Scale bars, 50 μm.) (E) Repre-
sentative images of X-Gal-stained testes from an adult Nanos2−/−mouse and
a WT mouse treated with busulfan to deplete the endogenous germline.
One testis of the Nanos2−/−mouse and the WT busulfan-treated mouse were
transplanted with SSCs from an allogeneic Rosa26-LacZ;Nanos2+/+ donor
mouse and the other testis was nontransplanted. Intense blue staining in the
transplanted testes reflect donor SSC engraftment and rederivation of
spermatogenesis.
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the recipients were paired with pubertal CD1 females to test
their fertility. Copulatory plugs were observed for all of the re-
cipients, confirming that mating occurred, and three of the six
males began siring offspring between 81 and 113 d after trans-
plant, including two recipients in which only one testis was
transplanted (SI Appendix, Table S2). Over the course of a 6- to
8-mo period, the fertile recipients produced 33 litters and 111
total offspring (SI Appendix, Table S2). Based on both coat color
and detection of the LacZ transgene, 100% of the offspring were
determined to be of donor genetic origin (Fig. 2 B and C). In-
terestingly, all of the recipients that attained fertility were
transplanted with donor SSCs at 21 to 28 days of age and re-
ceived <1 × 105 cells per testis; none of the recipients older than
28 days of age at transplant attained fertility. Amazingly, one of
the fertile recipients received only 3 × 104 cells into just one
testis (SI Appendix, Table S2). Recipients that did not attain
natural fertility were killed between 11 and 12 mo after trans-
plantation; all testes contained extensive colonies of donor-
derived spermatogenesis but the epididymal sperm content was
surprisingly low (SI Appendix, Fig. S2). At 1 year of age (∼11 mo
after transplantation), we killed the fertile recipients and similar
to the infertile counterparts, testes contained extensive donor-
derived spermatogenesis (Fig. 2D). In contrast to the infertile
recipients, sperm content in the epididymides of fertile recipients
was abundant (SI Appendix, Fig. S2). In addition, the average
weight of testes for recipients that attained natural fertility was
significantly greater (P < 0.05) compared to recipients that did
not attain fertility (Fig. 2E). Interestingly, the attainment of
natural fertility was significantly associated with a younger age at
the time of transplantation (Fig. 2F). Collectively, these findings
demonstrate that allogeneic donor SSC engraftment and sper-
matogenic regeneration in testes of prepubertal Nanos2 KO re-
cipient male mice is robust enough to yield persistent natural
fertility.
Donor-Derived Spermatogenesis Following Allogeneic SSCT in
NANOS2 Knockout Boars. Translation of the SSCT concept from
mice to livestock has been touted for nearly two decades as a
next generation breeding tool to expand the availability of sperm
from genetically desirable sires (8). However, advancement from
concept to reality has been limited, due in part to lack of ef-
fective approaches for preparing transplant recipient males. For
SSC transplant to be implemented in livestock production, re-
cipient males must completely lack endogenous germline to
optimize SSC engraftment and ensure that all sperm production
is of donor origin. In addition, somatic support cell function must
be maintained in the recipient testes to provide an environment
that will foster regeneration of normal spermatogenesis. As a
first step in developing potentially ideal livestock recipients, we
previously utilized CRISPR-Cas9-based gene editing to engineer
pigs (Duroc breed) with inactivating mutations in the NANOS2
gene and found that homozygous KO males possess testes with
intact seminiferous tubules and normal hormone production but
complete ablation of the germline, thus mirroring the phenotype
Fig. 2. Nanos2 knockout recipient mice attain natural fertility following allogeneic SSCT. (A) Schematic of the experimental strategy. (B) Image of a
CD1 Nanos2 knockout SSCT recipient and CD1 wild-type female breeder pair with litter of offspring possessing the SSCT donor haplotype. (C) Image of X-Gal-
stained tail biopsies from CD1 parents (Nanos2 knockout SSCT recipient male and wild-type female) and offspring generated by natural mating for LacZ
transgene activity that would be inherited from the SSCT donor. (D) Image of an X-Gal-stained testis from a CD1 Nanos2 knockout 11 mo after allogeneic SSCT
with stem cells from a LacZ transgenic donor male. The Nanos2 knockout recipient had attained fertility via natural mating. (E) Quantitative comparison of
testis weights for Nanos2 knockout recipients that did (+) or did not (−) attain fertility via natural mating following allogeneic SSCT. Data are mean ± SEM for
n = 3 to 9 different males of each recipient outcome. (F) Comparison of age at the time of allogeneic SSCT for Nanos2 knockout recipients that did (+) or did
not (−) attain natural fertility. Data are mean ± SEM for n = 3 different males of each recipient outcome. For E and F, * denotes significantly different at
P < 0.05.
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of Nanos2 KO mice (18). To explore whether a NANOS2 KO
male pig could serve as a surrogate for regeneration of donor sper-
matogenesis following SSCT, we cloned a founder male that pos-
sessed 150-bp and 4-bpΔ NANOS2 alleles (boar #146) using somatic
cell nuclear transfer. In total, six clones were generated (boars #132,
133, 134, 135, 136, and 137) and all were verified as knockouts for
NANOS2 by genotyping (SI Appendix, Fig. S3). In addition, following
the killing of boar #146, we examined >500 cross-sections of testic-
ular parenchyma taken from regions throughout the testis and did
not observe any seminiferous tubules with spermatogenesis (SI Ap-
pendix, Fig. S3), thus confirming the phenotype of endogenous
germline ablation.
At ∼4 months of age, either one or both testes of four boars
(#132, 134, 135, and 137) were injected with an unfractionated
single-cell suspension from total testicular tissue of an allogeneic
mixed breed wild-type donor boar. One of the boars (#133)
developed osteopathic degeneration and was killed and another
boar (#136) was left as a nontransplanted control. The donor cells
were transferred into the NANOS2 knockout recipient testes using
a variation of previously described methodology for ultrasound-
guided injection into the rete testis (12) (Fig. 3A and SI Appendix,
Table S3); however, successful infusion into seminiferous tubules
was not observed by ultrasound imaging. Regardless, at puberty
(∼6 months of age), all NANOS2 KO boars began semen collec-
tion on a regular basis to assess the presence of cells in the ejac-
ulate. Similar to the founder and as expected due to not observing
infusion of donor cell suspension into seminiferous tubules, sperm
were never observed in the ejaculates of any NANOS2 KO clone
over a ∼6-mo period of collection, thus confirming the azoo-
spermic phenotype due to germline ablation and unsuccessful
donor cell transplantation. Then, at 14 to 15 months of age, four
of the NANOS2 KO boars (#132, 134, 135, and 137) were again
transplanted with allogeneic wild-type donor cells (SI Appendix,
Table S3). For the second transplantation, the donor testicular cell
suspension was enriched for undifferentiated spermatogonia using
a multiparameter approach which, based on immunostaining for
the marker ZBTB16, consisted of ∼70% spermatogonia (SI Ap-
pendix, Fig. S4).
Beginning 50 d after the second transplantation procedure, the
recipient boars were again subjected to semen collection. Similar
to the pretransplantation collections, no cells were observed in the
ejaculates (Fig. 3B). However, at 90 d posttransplantation, we
began to observe round cells with a nuclear morphology similar in
appearance to spermatocytes and dividing round spermatids, as
described in the World Health Organization manual for human
semen evaluation, in two of the transplanted animals, boars #134
and 135 (Fig. 3B). Then, beginning at ∼100 d posttransplantation,
sperm appeared in the ejaculate of transplanted boar #135
(Fig. 3B). In addition, the sperm were of normal morphology,
motile (Movie S1), and persisted in the ejaculate for >200 d
posttransplantation (Fig. 3B). Unfortunately, the health of boar
#134 deteriorated shortly after observing round cells in the ejac-
ulate due to osteopathic degeneration which necessitated its kill-
ing. Importantly, neither round cells nor sperm were ever
observed (>400-d assessment period) in the ejaculate of the
nontransplanted boar #136. To confirm that the sperm produced
in testes of recipient boar #135 were derived from transplanted
donor SSCs, we isolated them from the ejaculate and carried out
PCR genotyping for the NANOS2 gene. As expected, two differ-
ent sized products were generated by PCR with DNA isolated
from hair follicles of the recipient, both of which were smaller in
size compared to an amplicon generated from DNA of a wild-type
boar (Fig. 3C), and these were confirmed by sequencing analysis
to be 4-bp and 150-bp Δ mutations (Fig. 3D). Importantly, PCR of
genomic DNA from the isolated sperm generated an amplicon of
identical size to wild type (Fig. 3C), which was confirmed by se-
quencing to be an intact NANOS2 allele (Fig. 3D). At ∼2 y after
transplant, boar #135 was killed due to advanced age and sperm
were detectable in the epididymal flushing (Fig. 3B). Moreover, his-
tological assessment of testis cross-sections revealed that spermato-
genesis was occurring in ∼15% of seminiferous tubules (Fig. 3E), and
sperm were observable in cross-sections of epididymal tubules
(Fig. 3F). As expected from lack of sperm in the ejaculate, sper-
matogenesis was not detected in any seminiferous tubule or epi-
dydimal cross-section examined (n = 400 to 500) for the
nontransplanted boar #136 (SI Appendix, Fig. S5). Collectively, these
results demonstrate that similar to mice allogeneic donor SSC en-
graftment and spermatogenesis can occur in testes of NANOS2 KO
recipient boars that are ablated of endogenous germline.
Generation of NANOS2 Knockout Bucks and Donor-Derived Spermatogenesis
Following Allogeneic SSCT.Next, we aimed to extend the SSCT concept
with NANOS2 KO surrogate males to agriculturally relevant ruminant
species. Because of ease in handling and a generation interval that is
relatively short compared to larger ruminants like cattle, we started
with goats as a model. To generate NANOS2 KO males for pheno-
typing and SSCT, somatic cell nuclear transfer (SCNT) was used (19)
with the nuclear DNA donor deriving from XY fetal fibroblasts of
Nubian × Boer crossbred male goats that were modified by CRISPR-
Cas9 editing to possess 16-bp and 23-bp NANOS2 Δ alleles (SI Ap-
pendix, Fig. S6). In total, 125 one-cell-stage cloned embryos were
generated and surgically transferred into seven estrous synchronized
recipients. At 40 to 45 d of gestation, five recipients were confirmed
pregnant by ultrasonography which yielded fiveNANOS2mutant bucks
being born alive (buck ID #901, 902, 904, 905, and 906) and all de-
veloped normally from birth to adulthood (Fig. 4 A and B and SI
Appendix, Table S4). At the pubertal age of 4 mo, a single-cell sus-
pension enriched for undifferentiated spermatogonia (∼60% based on
immunostaining for the marker ZBTB16, SI Appendix, Fig. S4) that
was isolated from testes of an age matched Lamancha breed donor
male was transplanted into either one or both testes of all NANOS2
KO bucks using an ultrasound-guided rete testis injection procedure
similar to that used for boars (Fig. 4C and SI Appendix, Table S5). At
the time of transplant, testicular biopsies were also obtained for his-
tological assessment. Identical to the phenotype of NANOS2 KOmice
and pigs, the KO bucks contained intact seminiferous tubules but
germline was not evident in testicular cross-sections (Fig. 4D), which
was confirmed by undetectable immunostaining for the spermatogonial
marker ZBTB16 (Fig. 4E). To assess whether donor-derived sper-
matogenesis was occurring in the NANOS2 KO recipients following
SSCT, we began collecting ejaculates from the bucks at ∼80 d after
SSCT. At ∼85 d after transplant, round cells were present in the
ejaculates of three recipients (buck ID #901, 902, and 906) and sperm
became evident beginning at 136 d after transplant in one buck (buck
ID #902), which we confirmed was derived from transplanted donor
SSCs by genotyping for an intact NANOS2 allele that was present in
cells derived from the Lamancha donor males (Fig. 4 F and G). In
addition, the sperm were of normal morphology and motile (Fig. 4F
and Movie S2). These findings demonstrate unequivocally that
germline-ablated NANOS2 KO bucks can serve as recipients for
allogeneic SSCT.
Generation of NANOS2 Knockout Cattle. Lastly, given the success
with goats, we aimed to generate NANOS2 KO cattle to deter-
mine if the phenotype of male-specific germline ablation is
conserved in a larger ruminant. To achieve this, electroporation-
based CRISPR-Cas9 editing of in vitro-produced embryos was
carried out using methodology that we recently described (16).
In total, 32 blastocyst-stage embryos were transferred into 16
estrous synchronized multiparous recipient cows, resulting in
eight pregnancies, one of which ended in preterm stillbirth of a
bull calf at ∼8 mo of gestation and two of which progressed to
term resulting in live birth of one heifer calf and one bull calf
(Fig. 5A and SI Appendix, Fig. S7 and Table S6). Both live born
calves were of normal birth weight and developed in a manner
consistent with possessing normal physiology (SI Appendix, Table
4 of 10 | www.pnas.org/cgi/doi/10.1073/pnas.2010102117 Ciccarelli et al.
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S7); likewise, the stillborn calf was of normal weight and size for
an 8-mo-old bovine fetus. Genotyping analysis revealed that the
preterm stillbirth calf and live heifer calf were NANOS2 KO with
both possessing biallelic editing of inactivating 11- or >300-bp Δ
mutations, respectfully (SI Appendix, Fig. S7). In corroboration
of the genotyping analysis, examination of cross-sections from
testicular parenchyma from the stillborn NANOS2 KO calf
revealed intact seminiferous cords and the presence of soma but
absence of germ cells (Fig. 5B), which was confirmed by lack of
immunostaining for the conserved germ cell marker DDX4 but
detectable immunostaining for the somatic Sertoli cell marker
SOX9 (Fig. 5C). Interestingly, genotyping of DNA isolated from
different cell lineages revealed that the live born bull calf was
mosaic for edited NANOS2 alleles; note that mosaicism is a
common occurrence in model organisms such as mice and pigs
when CRISPR-Cas9 reagents are delivered to zygotes (18, 20).
For the blood cell lineage which derives from embryonic meso-
derm, genomic DNA sequencing analysis of cloned PCR
amplicons (n = 14) detected intact NANOS2 alleles at a fre-
quency of 20% and INDEL mutated alleles detected at a fre-
quency of 80% (SI Appendix, Fig. S7). In contrast, analysis of
genomic DNA from hair follicle cells, which derives form em-
bryonic ectoderm, revealed that 100% of NANOS2 amplicons
(n = 16) contained INDEL mutations (SI Appendix, Fig. S7). To
assess the extent of NANOS2 editing in primordial germ cells
(PGCs) from which the spermatogenic lineage derives, biopsies
of testicular tissue were collected from the mosaic bull calf at
4 months of age. Similar to the stillborn fetal calf, germ cells
were undetectable in cross-sections of parenchyma but seminif-
erous tubules were intact with apparent somatic cells and these
observations were confirmed by lacking immunostaining for
DDX4 but detectable staining for SOX9 (Fig. 5C). Collectively,
these findings solidify that NANOS2 is evolutionarily conserved
as a specific regulator of male germline establishment and in-
dicate that CRISPR-Cas9-based inactivation can produce sur-
rogate sires for many, if not all, mammalian species.
Discussion
Developing applications of SSCT could impact society in several
ways including the combating of male infertility, preserving en-
dangered species, and altering the genetic makeup of livestock
populations. In particular, deployment as a breeding tool in
Fig. 3. Donor-derived spermatogenesis following allogeneic SSCT in NANOS2 knockout boars. (A) Schematic of the experimental strategy. (B) Representative
images portraying donor-derived spermatogenic regeneration in a NANOS2 KO recipient boar (#135) following allogeneic SSCT. (Scale bars, 10 μm.) (C)
Representative image of PCR-based genotyping for NANOS2 alleles with DNA samples isolated from testicular tissue of a wild-type (NANOS2+/+) boar, as well
as hair follicles, total ejaculate, and sperm collected from a NANOS2 KO recipient subjected to allogeneic SSCT with stem cells from a wild-type (NANOS2+/+)
donor boar. Molecular weight (MW) is 100-bp DNA ladder. (D) Outputs from DNA sequencing analysis of PCR-based genotyping products showing detection
of 4-bp and 150-bp NANOS2 deletion (Δ) alleles from hair follicle samples and intact NANOS2 allele from sperm samples both from a NANOS2 KO recipient
boar subjected to allogeneic SSCT with wild-type donor stem cells. (E) Representative images of hematoxylin & eosin-stained cross-sections of testicular
parenchyma from NANOS2 KO boars transplanted with donor SSCs or nontransplanted. (Scale bars, 50 μm.) (F) Representative images of hematoxylin & eosin-
stained cross-sections of epididymal tubules from NANOS2 KO boars transplanted with SSCs or nontransplanted. (Scale bars, 50 μm.)
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livestock—the surrogate sire concept—has the potential to dra-
matically enhance genetic gain on a worldwide scale to improve
production characteristics for generating meat, milk, and fiber
for human consumption (8, 21). Considering that broad utility of
such a concept will require allogeneic transfer in diverse live-
stock production systems including range settings or smallholder
regions of the developing world, intensive management of an
SSCT recipient for immune suppression will not be feasible.
Here we demonstrate unequivocally that neither allogeneic do-
nor SSCs nor the spermatogenic lineage derived from them are
immunologically rejected when transferred into the testes of
NANOS2 KO recipient male mice, pigs, and goats that possess a
fully functional immune system. Furthermore, using the experi-
mentally tractable mouse model we show that NANOS2 KO
Fig. 4. Donor-derived spermatogenesis following allogeneic SSCT in germline-ablated NANOS2 knockout bucks. (A) Image of five NANOS2 KO bucks
generated by somatic cell nuclear transfer of CRISPR-Cas9 gene-edited fetal goat fibroblasts. (B) Outputs from DNA sequencing analysis of PCR-based
genotyping products showing 16-bp and 23-bp NANOS2 deletion (Δ) alleles. (C) Schematic for SSCT in NANOS2 KO bucks. Prepubertal Lamancha breed
(dwarf ear) males were used as a source of donor SSCs. (D) Representative images of hematoxylin & eosin-stained cross-sections of testicular parenchyma from
WT and NANOS2 KO bucks at 4 months of age. (Scale bars, 100 μm.) (E) Representative images of immunofluorescent staining for the spermatogonial marker
ZBTB16 in cross-sections of testes from 4-mo-old wild-type and NANOS2 KO bucks. (Scale bars, 100 μm.) (F) Representative images of spermatids and sperm in
the ejaculates of NANOS2 KO bucks that arose 85 to 136 d after donor SSCT. (Scale bar, 10 μm.) (G) Representative image of an agarose gel for visualizing
RFLP-based genotyping for NANOS2 alleles with genomic DNA isolated from sperm in NANOS2 KO buck ejaculates and hair follicles from wild-type or
NANOS2 KO bucks. The mutation generated by CRISPR-Cas9 editing of the caprine NANOS2 genomic DNA sequence removed a BmrI restriction enzyme site
present in wild-type DNA, thereby rendering the sequence resistant to cleavage.
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recipients can attain natural fertility following SSCT and 100%
of offspring possess the donor haplotype. These findings provide
compelling support for feasibility of developing the surrogate
sire concept in all animals including endangered species and
livestock.
Although several previous studies have suggested that SSCT is
possible in livestock, including pigs (11, 12), cattle (14, 15), sheep
(22), and goats (13), none have reduced the approach to a
context that would be applicable in an agricultural production
setting. In particular, all have used cytotoxic treatments in at-
tempts to eliminate the endogenous germline of recipients which
is well known to have detrimental effects on the health of the
animal and harm the somatic support structure of the testis
(23–25). In addition, the cytotoxic treatment approaches devised
to date are not able to produce complete ablation of the en-
dogenous germline, with remaining resident SSCs able to rees-
tablish spermatogenesis over time. Indeed, studies with mice
have shown that all SSCT recipients treated with busulfan pro-
duce offspring from endogenous germ cells (10). Here, we
demonstrate that testes of male pigs and goats with genetic de-
ficiency in a germ cell-specific gene (NANOS2) that leads to
complete germline ablation can be a surrogate host for
regeneration of spermatogenesis from transplanted wild-type
SSCs. This achievement is a demonstration, outside of mice, of
spermatogenic regeneration in a genetically sterile male by SSCT.
To be tractable in a livestock production setting, SSCT must
produce recipients with a level of donor-derived sperm produc-
tion similar to that of normal males in order to achieve fertility in
a natural breeding setting. Although a level comparable to that
of a normal wild-type male was not achieved, we show that with a
mouse model, natural fertility is attained when Nanos2 KO
males are used as recipients. However, with pigs and goats,
technical refinements are needed to achieve a greater level of
donor-derived spermatogenesis. While a high level of donor SSC
engraftment occurred in all Nanos2 KO recipient mice, only
those that were less than 28 days of age at the time of transplant
were able to produce offspring. This age point would be con-
sidered as prepubertal in a wild-type context, suggesting that
SSCT must occur prior to when the testicular soma would nor-
mally mature in order for natural fertility to be attained. Indeed,
previous studies showed that donor SSC engraftment is nearly
fivefold greater in wild-type recipient mice transplanted as pre-
pubertal pups (4 to 8 days of age) compared to adults (26).
Translating from mouse to large animals, SSCT should occur
Fig. 5. Germline ablation in NANOS2 knockout male cattle. (A) Pictures of a NANOS2 mosaic bull calf at 2 days, 1 month, and 4 months of age that was
generated by CRISPR-Cas9 editing of a bovine zygote and embryo transfer. (B) Representative images of hematoxylin & eosin-stained cross-sections of tes-
ticular parenchyma from a WT bull calf at 4 months of age, NANOS2 KO fetal bull calf at 253 d of gestation, and NANOS2mosaic bull calf at 4 months of age.
(Scale bars, 50 μm.) Arrows indicate examples of germ cells in wild-type testes. (C) Representative images of immunohistochemical staining for germ cells
(DDX4+) or Sertoli cells (SOX9+) in cross-sections of testicular parenchyma from a WT bull calf at 4 months of age, NANOS2 KO fetal bull calf at 253 d of
gestation, and NANOS2 mosaic bull calf at 4 months of age. (Scale bars, 50 μm.) Arrows indicate examples of DDX4-stained germ cells and SOX9-stained
Sertoli cells.
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prior to puberty to produce a high level of donor-derived sper-
matogenesis. In the current study, successful injection of donor
cells into NANOS2 KO recipient pigs and goats occurred when
they were past what would be consider a prime window of pre-
pubertal development. In addition, with mice, over two decades
of refinements for optimizing the several aspects of SSCT have
occurred such as the volume of cell suspension transferred,
number of donor cells, and route of injecting the donor cell
suspension into recipient seminiferous tubules. Although we
have demonstrated biological proof of concept in the current
study that testes of NANOS2 KO livestock are able to harbor
regeneration of spermatogenesis from a transplanted donor SSC,
several simple technical refinements to the injection procedure
are likely to generate surrogate males that could be used in a
natural breeding scheme.
An unanticipated complication of the cohort of NANOS2 KO
boars used in the current study was a relatively high incidence of
osteopathic degeneration which occurred in two of the six ani-
mals. If caused by NANOS2 deficiency, this nuance could limit
utility of KO males for breeding purposes. Considering that all of
the boars were clones from a single nuclear transfer donor boar
that had been generated by CRISPR-Cas9 editing in our previ-
ous studies who did not experience osteopathic degeneration
(18), abnormalities brought about by the cloning procedure
could be the cause. However, potential off-target editing by the
NANOS2 CRISPR in the nuclear transfer donor boar cannot be
ruled out as a contributor of the degeneration phenotype. Also,
osteopathic degeneration or a similar abnormality was not ob-
served with NANOS2 KO animals of any of the other species that
we studied, thus indicating that NANOS2 deficiency was not a
major contributor to the phenotype.
Beyond the utility as a next generation breeding tool in live-
stock production, SSCT with NANOS2 KO males could be an
invaluable alternative to the current standards of busulfan and
irradiation treatments to eliminate endogenous germline. Im-
portantly, because Nanos2−/− female and Nanos2+/− male mice
are fertile, KO recipients can be efficiently produced by simple
cross-breeding. With mice, we found that the level of donor SSC
engraftment in Nanos2 KO recipients is greater compared to
conventional wild-type recipients prepared by busulfan treat-
ment. Considering the relative ease of producing Nanos2 KO
males by cross-breeding, use of cytotoxic treatments to prepare
SSCT recipient males may very likely be unnecessary in all re-
search and application settings which will also reduce welfare
concerns of subjecting animals to harsh chemicals. Beyond the
mouse, generating any animal model that harbors NANOS2
mutant alleles including rodents, domestic livestock, companion
animals, or endangered species, is technically feasible using
CRISPR-Cas9 technology. For endangered species, combining
the generation of NANOS2 mutant animals with SSCT may
provide a viable means for preserving unique genetics and pro-
viding an option for conservation.
For many types of stem cell transplantation, allogenecity is a
major limiting factor which often results in immunological re-
jection of the donor cells. For example, the effectiveness of he-
matopoietic stem cell transplantation for rodents and humans is
compromised when the donor and recipient are histoincompat-
ible (27, 28). Previous studies with mice indicated that allogeneic
SSCT was not tolerated due to recipient immunological rejection
(9, 10); but, studies with pigs (11, 12), goats (13), and cattle (14,
15) have detected the presence of donor DNA in the ejaculates
of recipient males following injection of a testis cell suspension
from an allogeneic donor, suggesting immune tolerance. For
pigs, assessment of SSCT success has relied on detection of a
transgenic DNA sequence in the ejaculate of recipients that
presumably integrated into donor germ cells via exposure of the
mixed testicular cell suspension to a viral vector prior to trans-
plantation and detection of the same sequence in embryos
produced by in vitro fertilization with sperm of the recipient (11).
For goats, a previous study showed that one out of five recipient
goats transplanted with an allogeneic donor testis cell suspension
generated a single offspring (out of 15 produced by the recipient)
that possessed donor transgene DNA (13). For cattle, demon-
stration of sperm being the source of donor DNA sequence has
not been definitively shown by previous studies. Although these
findings are encouraging, all large animal recipients used to date
have possessed endogenous germline, albeit depleted by busul-
fan treatment or localized testicular irradiation in some cases,
which makes clear determination of donor-derived spermato-
genesis challenging. In the present study, we demonstrate un-
equivocally that allogeneic SSCT in mice, pigs, and goats is
immunologically tolerated, leading to extensive engraftment and
persistent donor-derived spermatogenesis at a level sufficient to
yield fertility, at least in the case of mice. Furthermore, our
findings are experimental evidence of regenerating the sper-
matogenic lineage via SSCT in genetically sterile male livestock
that lack endogenous germline. Moreover, our discovery that
inactivation of NANOS2 also leads to germline ablation in male
cattle opens the intriguing possibility of one day developing bull
“super dads” that then can be harnessed for disseminating de-
sirable genetics in cattle populations around the world (29). We
predict that the accomplishments reported here will serve as a
springboard for future refinement of methodology to establish
the surrogate sire concept as a predominant breeding tool in all
sectors of food animal production.
Methods
Animals. All animal procedures were approved by the Institutional Animal
Care and Use Committees of Washington State University, the University of
Maryland, and Utah State University. All mouse lines were originally procured
from Charles River Laboratories, CD1/ICR (stock no. 022) or The Jackson
Laboratory, Rosa26-LacZ (stock no. 002073), C57BL6/J (stock no. 000664), and
129S1/svlmJ (stock no. 002448). Boars that served as a source of donor SSCs
for transplantation were of mixed domestic breeds and SSC donor bucks
were of the dwarf-eared Lamancha breed.
Generation of NANOS2 Gene Edited Animals.
Mice. To produce CD1 Nanos2 knockout male mice, females that were ho-
mozygous and males that were heterozygous for inactive Nanos2 alleles,
which were engineered in previous studies using CRISPR-Cas9 technology
(16), were mated.
Pigs. The production of NANOS2 knockout boars to serve as SSCT recipients
involved SCNT with fibroblasts isolated from a mature boar engineered in
previous studies using CRISPR-Cas9 technology to possess 4-bp and 150-bp Δ
alleles (18). The SCNT procedure was as described previously (30). In total, six
NANOS2 knockout cloned boars were produced and all developed normally
from birth to adulthood and were azoospermic, thus mirroring the pheno-
type of the SCNT donor.
Goats. Fetal fibroblasts from a Nubian × Boer donor were transfected with a
Cas9/sgRNA3 plasmid vector engineered to express a sgRNA targeting the
caprine NANOS2 genomic DNA sequence (SI Appendix, Fig. S6 and Cas9
mRNA as described previously) (31, 32). Gene mutation efficiency was de-
termined by PCR/restriction fragment length polymorphism (RFLP) assays.
Single-cell-derived NANOS2 knockout fibroblast colonies were isolated by
limiting dilution and used for SCNT as cell donors. The SCNT procedure was
performed as described previously (19). In total, five NANOS2 knockout
cloned bucks were produced and developed normally to adulthood. PCR/
RFLP assays and Sanger sequencing were used for the genotyping of
cloned animals.
Cattle. Bovine zygotes were generated using an in vitro production system
and electroporated with CRISPR-Cas9 reagents designed to edit the NANOS2
gene, as we have described previously (16). Embryos were then cultured to
the early blastocyst stage (developmental day 6) using methodology de-
scribed previously (16), and those that were scored as grades 1 to 2 were
transferred into uterine horns of day 7- to 9-pseudopregnant recipient cows
or heifers whose estrous cycles had been synchronized using the 5-d con-
trolled internal drug release/cosynchronization protocol. For all recipients,
two embryos were transferred into the uterine horn ipsolateral to an ovary
possessing a robust corpus luteum using a standard nonsurgical technique.
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Pregnancy diagnosis was made at 60-d postembryo transfer using
ultrasonography.
Genotyping Analyses. Genomic DNAwas isolated from blood cells, hair follicle
cells, skin epithelial cells, and sperm using a DNAeasy kit (Qiagen, cat. no.
69504). Genotyping for NANOS2 alleles in mouse, pig, and cattle samples
was conducted using PCR and Sanger sequencing methodologies as de-
scribed previously (16). For goat samples, PCR was carried out with genomic
DNA and primers (forward: 5′-TGCTTAGAAGGGTCTTTGGG-3′, reverse: 5′-
CATAATGCCGCAGGATGG-3′) designed to recognize the full coding se-
quence for caprine NANOS2. The reaction produced a wild-type amplicon of
424 bp which contained a BmrI restriction enzyme site that was removed by
CRISPR-Cas9 editing which yielded GFF clones #82 and 25 that were used for
SCNT. Thus, genotyping for NANOS2 mutant alleles was carried out as an
RFLP assay that could be visualized with agarose gel electrophoresis; re-
striction enzyme digestion of the wild-type amplicon yielded fragments of
∼250 and 175 bp, whereas the CRISPR-Cas9 mutated alleles were resistant to
cutting.
Donor SSC Preparation and Transplantation.
Mice. Single-cell suspensions were generated from testes of adult Rosa26-
LacZ mice and the THY1+ fraction that is enriched for SSCs was then isolated
using magnetic-activated cell sorting as described previously (33, 34). Cells
were either transplanted as a fresh cell suspension or used to establish pri-
mary cultures as described previously (34) and expanded for a period of 2 mo
prior to collection as a single-cell suspension for transplantation. Both
freshly isolated and in vitro expanded donor cell populations were sus-
pended at a concentration of 2 to 5 × 106 cells/mL in mouse serum-free
media (34) and 2 to 5 μL was microinjected into seminiferous tubules of
each Nanos2 knockout recipient mouse testis as described previously (35).
Pigs and goats. Approximately 500 mg of parenchyma was collected from
prepubertal donor boar or buck testes and enzymatically disassociated using
a multistep method devised originally for bovine testicular tissue (36). The
resulting single-cell suspensions were then either transplanted as a mixed
testicular cell suspension containing germ cells and somatic cells (pigs only)
or placed in gelatin-coated plastic culture wells and incubated overnight in a
serum-free media designed for culture of mouse SSCs (34). After overnight
culture, the nonadherent cell suspensions, enriched for spermatogonia,
were isolated by gentle swirling of the plate and collection of the cell con-
taining media. For transplantation, the fresh mixed cell suspension or
enriched spermatogonial cell suspensions were suspended in serum-free
media at a concentration of 1 to 2 × 106 cells/mL. Next, NANOS2 knockout
recipient boars and bucks were placed under general anesthesia and posi-
tioned in lateral recumbency for infusion of donor cells into the rete testis
using a modified ultrasound-guided injection procedure described previ-
ously (12, 13, 37). Briefly, for each testis a 5-mm incision was made through
the scrotum of the dorsal side, ventral to the tail of the epididymis, and
parallel to the median raphe until visualization of the tunica albuginea. A
stub incision was then made through the tunica albuginea and an IV cath-
eter was inserted through the incision as parallel as possible to the rete testis
which was visualized by ultrasonography using a 7.5-MHz linear transducer
positioned longitudinally with respect to the long axis of the testicle. Once
the tip of the catheter was visualized as being in the rete testis, the stylet
was removed and surgical glue was used to fix the catheter in position. Next,
an extension tubing set (Baxter; 21 inches, 2.4 mL) containing the donor cell
suspension was attached to the catheter and a syringe without plunger was
attached to the other end of the tubing. The plunger was then added and
the solution was allowed to flow into the rete testis which could be visual-
ized by ultrasonography. After the entire cell suspension had been infused,
the catheter was removed and scrotal skin incision closed with suture. To
facilitate proper positioning, the right testicle was injected with the recipi-
ent boar or buck in left lateral recumbency and vice versa.
Histological Analysis and X-Gal Staining. For histological analysis, testicular
and the epididymal tissues were fixed in Bouin’s solution for 1 h followed by
dehydration in graded series of ethanol and xylenes and then embedded in
paraffin. Cross-sections of 5 μm were generated with a microtome and ad-
hered to glass slides followed by dewaxing and rehydration. For morpho-
logical assessment, cross-sections were stained with hematoxylin & eosin
followed by evaluation using light microscopy and digital images were
captured at 100 to 200× magnification with an Olympus IX51 and TH4-100
digital camera using CellSens Dimensions software. For mouse studies, as-
sessment of donor-derived colonies of spermatogenesis in recipient testes
was accomplished by staining with X-Gal as described previously (35).
Immunostaining Analyses.
Tissue cross-sections. Parrafin cross-sections (5-μm thickness) adhered to glass
slides were dewaxed and rehydrated. The sections were then processed for
antigen retrieval by incubating in an acidic (pH 6.0) solution of 10 mM so-
dium citrate (Amresco, cat. no. 0101) and 0.05% Tween-20 (Sigma-Aldrich,
cat no. P1379) for 20 min at 96 °C. Nonspecific antibody binding was then
blocked by incubating sections in a solution containing 2% bovine serum
albumin (BSA) (Thermo Fisher Scientific, cat. no. BP1600) and 0.1% Triton X-
100 (Sigma-Aldrich, cat. no.T8787) in phosphate-buffered saline (PBS) at
room temperature for 2 h. Sections were then incubated overnight at 4 °C
with a primary antibody: rabbit anti-human ZBTB16 (Santa Cruz Biotech-
nology, cat. no. sc22839) at 1:200; rat anti-mouse TRA98 (Abcam cat. no.
ab82527) at 1:500; rabbit anti-human DDX4 (Abcam, cat. no. ab13840) at
1:100 to 200; or rabbit anti-human SOX9 (Millipore, cat. no. AB5535) at
1:200. Sections were washed in PBS and then incubated at room tempera-
ture for 2 h with a secondary antibody: Alexa Fluor 488 goat anti-rabbit IgG
(Invitrogen, cat. no. A-11008) at 1:1,000; DyLight 594 goat anti-rat IgM
(Invitrogen, cat. no. SA5-10012) at 1:1,000; horseradish peroxidase donkey
anti-rabbit IgG (Vector Labs, cat. no. pk6200) at 1:1,000 followed by washing
in PBS, counterstaining with hematoxylin or DAPI, and mounting of cover-
slips. Images were captured using an Olympus IX51 or Leica DMi8
microscope.
Cells. Single-cell suspensions of multiparameter selected or unselected tes-
ticular populations from pigs and goats were adhered to poly-L-lysine-
coated plastic dishes and subsequently fixed in 4% paraformaldehyde for
10 min at 4 °C. Cells were then incubated in PBS containing 0.1% Triton X-
100 to permeabilize membranes, and nonspecific antibody binding was
blocked by incubation with 10% normal serum in PBS at room temperature
for 5 min. Cells were again washed with PBS and then incubated overnight
at 4 °C with primary antibodies diluted in PBS containing 0.5% BSA and
0.1% Triton X-100: rabbit anti-human ZBTB16 (Santa Cruz Biotechnology,
cat. no. sc22839) at 1:200 or mouse anti-human UCHL1 (Bio-Rad, cat. no.
78631004) at 1:200. On the next day, cells were washed in PBS and incubated
with secondary antibody for 1 h at 4 °C: Alexa Fluor 488 goat anti-rabbit IgG
(Invitrogen, cat. no. A-11008) at 1:1,000; or Alexa Fluor 546 donkey anti-
mouse IgG (Invitrogen, cat. no. A10036). Cells were again washed in PBS,
then incubated with DAPI to label their nuclei, viewed by fluorescent mi-
croscopy, and digital images were captured with a DP72 camera and CellSens
acquisition software. Quantification of the percentage of cells in multipa-
rameter and unselected cell populations that were ZBTB16+ was achieved by
counting fluorescently stained cells in five different fields of view for each
well and dividing by the number of DAPI-stained nuclei that were present in
the same fields of view.
Assessment of Germline Presence, Spermatogenesis, and Fertility.
Mice. Presence of spermatogenic lineage in testes of Nanos2 KO mice was
assessed by histomorphological examination of testis cross-sections. The
fertility of all mice was assessed by pairing of one to two pubertal-aged
females with a single male for periods of 1 to 6 mo and the number of
pups born per month was recorded. Detection of LacZ activity by X-Gal
staining was used to assess donor-derived spermatogenesis in Nanos2 KO
recipient mice following SSCT. Both coat color and LacZ expression from
X-Gal staining of tail tips were used to determine whether offspring pro-
duced by Nanos2 KOs following SSCT were from donor-derived sperm.
Pigs, goats, and cattle. Histomorphological examination and immunostaining
for DDX4 and SOX9 were used to determine the presence of spermatogenic
lineage and Sertoli cells in cross-sections of testes, respectively. To assess the
degree of spermatogenesis throughout testes of NANOS2 knockout boars
subjected to SSCT or nontransplanted controls, ∼100-mg pieces of paren-
chyma were collected from 50 different regions in a manner that repre-
sented the entire tissue mass. For quantification, 500 to 600 cross-sections
(n = 10 to 12 per tissue piece) were examined using light microscopy, and the
number of tubules with or without spermatogenesis was scored. To assess
the presence of sperm in the ejaculate of boars and bucks, a semen collec-
tion phantom or teaser doe in estrus was used, respectively.
Data Availability. All study data are included in the article and supporting
information.
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